<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01435408</url>
  </required_header>
  <id_info>
    <org_study_id>DANAMI-3</org_study_id>
    <nct_id>NCT01435408</nct_id>
  </id_info>
  <brief_title>DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction</brief_title>
  <acronym>DANAMI-3</acronym>
  <official_title>A Randomised Comparison of the Clinical Outcome After Postconditioning or Deferred Stent Implantation Versus Conventional Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study focuses on Cardioprotective strategies.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality, heart failure (postconditioning)</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infarct size in relation to area at risk as determined by MRI after 3 month</measure>
    <time_frame>3 month</time_frame>
    <description>Infarct size Salvage index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality, myocardial infarction, repeat revascularisation and occurrence of definite stent thrombosis according to ARC definition within 1 year (deferred stent strategy)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>TIMI flow</measure>
    <time_frame>postprocedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>ST-segment resolution</measure>
    <time_frame>90 min postprocedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Wall motion index (echo)</measure>
    <time_frame>1 year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>LVEF (MRI)</measure>
    <time_frame>90 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Infarct size (MRI)</measure>
    <time_frame>90 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Microvascular obstruction (MVO)</measure>
    <time_frame>within 48 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>ST Segment Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Conventional treatment.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional primary PCI in STEMI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IPost</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ischemic postconditioning in STEMI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deferred primary PCI.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Deferred strategy in STEMI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional primary PCI</intervention_name>
    <description>Conventional primary PCI in STEMI with implantation of DES.</description>
    <arm_group_label>Conventional treatment.</arm_group_label>
    <other_name>pPCI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ischemic postconditioning.</intervention_name>
    <description>Primary PCI in STEMI with implantation of DES. Following re-opening of the culprit artery mechanical postconditioning with 4 cycles of 30/30 sec. reperfusion/re-occlusion i performed.</description>
    <arm_group_label>IPost</arm_group_label>
    <other_name>Ischemic postconditioning</other_name>
    <other_name>Mechanical postconditioning</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deferred stenting in primary PCI.</intervention_name>
    <description>In STEMI re-opening of the artery with guidewire/thrombectomy/small size balloon inflation DES stenting is postponed for 48 hours.</description>
    <arm_group_label>Deferred primary PCI.</arm_group_label>
    <other_name>Deferred stenting</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years.

          -  Acute onset of chest pain of &lt; 12 hours' duration.

          -  ST-segment elevation ≥ 0.1 mV in ≥ 2 contiguous leads, signs of a true posterior
             infarction or documented newly developed left bundle branch block.

        Culprit lesion in a major native vessel.

        Exclusion Criteria:

          -  Pregnancy.

          -  Known intolerance of ASA, clopidogrel, heparin or contrast.

          -  Inability to understand information or to provide informed consent.

          -  Haemorrhagic diathesis or known coagulopathy.

          -  Stent thrombosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Koeber, Prof., DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Heart Center, Rigshospitalet, University of Copenhagen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Engstrom, MD, DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Heart Center, Rigshospitalet, University of Copenhagen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henning Kelbaek, MD, DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Heart Center, Rigshospitalet, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cardiology, Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>9100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology, Skejby University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Center, Rigshospitalet, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology, Gentofte University Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2011</study_first_submitted>
  <study_first_submitted_qc>September 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2011</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Thomas Engstrom</investigator_full_name>
    <investigator_title>MD, DMSci, PhD</investigator_title>
  </responsible_party>
  <keyword>STEMI</keyword>
  <keyword>Ischemic postconditioning</keyword>
  <keyword>Deferred stenting</keyword>
  <keyword>Primary PCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

